Krystal Biotech宣布了其肿瘤治疗项目KB707开发计划的最新进展,并表示将优先开发吸入式KB707用于非小细胞肺癌的治疗。该公司对KB707项目的战略重点进行了调整,聚焦于通过吸入给药方式来治疗非小细胞肺癌患者。
Krystal Biotech宣布了其肿瘤治疗项目KB707开发计划的最新进展,并表示将优先开发吸入式KB707用于非小细胞肺癌的治疗。该公司对KB707项目的战略重点进行了调整,聚焦于通过吸入给药方式来治疗非小细胞肺癌患者。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.